BMY - NYSE - 3/11/2010 8:00 PM
| Current | Overall Rank | Sector Rank | Industry Rank |
|---|---|---|---|
| $51.42B | 77 / 4696 | 12 / 559 | 10 / 22 |
| Healthcare | Drug Manufacturers - Major |
| Period | Market Cap |
|---|---|
| Sep/99 | $127.51B |
| Dec/99 | $121.10B |
| Mar/00 | $107.36B |
| Jun/00 | $109.28B |
| Sep/00 | $107.48B |
| Dec/00 | $137.50B |
| Mar/01 | $110.46B |
| Jun/01 | $96.67B |
| Sep/01 | $107.62B |
| Dec/01 | $98.68B |
| Mar/02 | $78.34B |
| Jun/02 | $49.78B |
| Sep/02 | $46.10B |
| Dec/02 | $44.84B |
| Mar/03 | $40.93B |
| Jun/03 | $52.63B |
| Sep/03 | $49.74B |
| Dec/03 | $55.46B |
| Mar/04 | $47.05B |
| Jun/04 | $47.64B |
| Sep/04 | $46.04B |
| Dec/04 | $49.85B |
| Mar/05 | $49.75B |
| Jun/05 | $48.82B |
| Sep/05 | $47.06B |
| Dec/05 | $44.96B |
| Mar/06 | $48.33B |
| Jun/06 | $50.60B |
| Sep/06 | $49.01B |
| Dec/06 | $51.76B |
| Mar/07 | $54.63B |
| Jun/07 | $62.11B |
| Sep/07 | $57.00B |
| Dec/07 | $52.47B |
| Mar/08 | $42.16B |
| Jun/08 | $40.64B |
| Sep/08 | $41.28B |
| Dec/08 | $46.03B |
| Mar/09 | $43.40B |
| Jun/09 | $40.23B |
| Sep/09 | $44.61B |
| 3/11 | $51.42B |
Interesting BioSante GVAX data in leukemia targets minimal residual disease post imatinib therapy http://bit.ly/96tBLZ $BPAX $NVS $BMY
MaverickNY about 15 hours ago.
$BMY (Bristol-Myers Squibb) $25.89 crossed its 1st Pivot Point Resistance #emppv #stocks http://empirasign.com/s/7y8
empirasign_eq about 17 hours ago.
RT @mhuckman: Small co, small study fyi RT @MaverickNY: My take on the BioSante GVAX data in leukemia: http://bit.ly/96tBLZ $BPAX $NVS $BMY
Newbietrader1 about 21 hours ago.
Small co, small study fyi RT @MaverickNY: My take on the BioSante GVAX data in leukemia: http://bit.ly/96tBLZ $BPAX $NVS $BMY
mhuckman about 22 hours ago.
My take on the BioSante GVAX data in leukemia: http://bit.ly/96tBLZ $GPAX $NVS $BMY
MaverickNY about 22 hours ago.
Obamacare? Who Cares? There Are Drug Deals To Do (at The Wall Street Journal Online)
Mar 10 03:49 PM EST.
$BMY (Bristol-Myers Squibb) $25.62 crossed its 3rd Pivot Point Resistance #emppv #stocks http://empirasign.com/s/7e8
empirasign_eq about 2 days ago.
Biotechs Jump on Facet, Intermune Deal - Stocks To Watch Today - Barrons.com $ITMN $ABT $FACT $OSIP $JNJ $BMY $BSX $XBI http://bit.ly/aJDahM
barronsstocks about 2 days ago.
RT @MaverickNY: The Abbott-Facet Biotech deal: Let the dance begin http://bit.ly/bJF2eH $ABT $FACT $BMY $BIIB
WriterChik about 2 days ago.
Abbot Bids 66% Premium for Facet’s Oncology Drugs - Stocks To Watch Today - Barrons.com $ABT $FACT $JNJ $PFE $BSX $BMY http://bit.ly/cEfsR7
barronsstocks about 2 days ago.
RT @mhuckman: 1 more thing on Bristol $BMY CEO $1.5m pay cut last yr. Still made $18.2m, but said @ analyst mtg last wk he'll soon "b on fixed income."
mccannpj about 2 days ago.
1 more thing on Bristol $BMY CEO $1.5m pay cut last yr. Still made $18.2m, but said @ analyst mtg last wk he'll soon "b on fixed income."
mhuckman about 2 days ago.
RT @odomlewis: RT @mhuckman: How's this 4 a change? Bristol $BMY says CEO Cornelius took $1.5m pay cut last yr. Still made $18.2m[obscene]
MeredithGould about 2 days ago.
RT @mhuckman: How's this 4 a change? Bristol $BMY says CEO Cornelius took $1.5m pay cut last yr. Still made $18.2m, tho.
odomlewis about 2 days ago.
The Abbott-Facet Biotech deal: Let the dance begin http://bit.ly/bJF2eH $ABT $FACT $BMY $BIIB
MaverickNY about 2 days ago.
RT @MaverickNY: The Abbott-Facet Biotech deal: Let the dance begin http://bit.ly/bJF2eH $ABT $FACT $BMY $BIIB
mhuckman about 2 days ago.
RT @mhuckman: How's this 4 a change? Bristol $BMY says CEO Cornelius took $1.5m pay cut last yr. Still made $18.2m, tho.
mccannpj about 2 days ago.
http://bit.ly/cvebly How's this 4 a change? Bristol $BMY says CEO Cornelius took $1.5m pay cut... http://bit.ly/awAEEL #stocks #MKT #forex
tradepips about 3 days ago.
RT @mhuckman: How's this 4 a change? Bristol $BMY says CEO Cornelius took $1.5m pay cut last yr. Still made $18.2m, tho.
pjmachado about 3 days ago.
How's this 4 a change? Bristol $BMY says CEO Cornelius took $1.5m pay cut last yr. Still made $18.2m, tho.
mhuckman about 3 days ago.
RT @empirasign_eq - $BMY (Bristol-Myers Squibb) $25.15 crossed its 1st Pivot Point Support #emppv #stocks http://brokerz.com/_FwM/
brokerz_spx about 3 days ago.
$BMY (Bristol-Myers Squibb) $25.15 crossed its 1st Pivot Point Support #emppv #stocks http://empirasign.com/s/6v6
empirasign_eq about 3 days ago.
RT @mhuckman: The Bristol/Astra $BMY $AZN Onglyza diabetic heart study is pretty big. 12,000 patients. 5 years. http://tinyurl.com/pmongbmaz
mccannpj about 3 days ago.
The Bristol/Astra $BMY $AZN Onglyza diabetic heart study is pretty big. 12,000 patients. 5 years. http://tinyurl.com/pmongbmaz
mhuckman about 3 days ago.
Bristol & AstraZeneca $BMY $AZN start post-market study to see if there's a heart effect w/new diabetes drug Onglyza.The acronym?SAVOR. Yum.
mhuckman about 3 days ago.
http://chart.ly/w3tvq8 $BMY - breakout of bull flag, but wait for sideways / down movement before entering for upside trade.
akoptiontrader about 4 days ago.
